| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/13/2001 | EP1105465A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 06/13/2001 | EP1105461A2 Methods of forming neurons |
| 06/13/2001 | EP1105460A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 06/13/2001 | EP1105428A1 Novel cleaved fragments of fibrinogen |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105420A1 Cyclic prosaposin-derived peptides and uses thereof |
| 06/13/2001 | EP1105419A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/13/2001 | EP1105418A1 Vanadate resistance glycosylation 4 gene |
| 06/13/2001 | EP1105417A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105413A2 Hepatitis c inhibitor tri-peptides |
| 06/13/2001 | EP1105412A1 Serine protease inhibitors comprising alpha-keto heterocycles |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105410A1 Purification of blood clotting proteins |
| 06/13/2001 | EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 06/13/2001 | EP1105408A1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 06/13/2001 | EP1105160A1 Lats knock-out animal models and their uses |
| 06/13/2001 | EP1105155A1 Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 06/13/2001 | EP1105154A1 Bacterial superantigen vaccines |
| 06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
| 06/13/2001 | EP1105151A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
| 06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 06/13/2001 | EP1105149A1 Methods to increase blood flow to ischemic tissue |
| 06/13/2001 | EP1105147A1 Methods for treatment of neurological disorders |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105142A2 Blood-brain barrier therapeutics |
| 06/13/2001 | EP1105100A1 Alginate capsules for use in the treatment of brain tumour |
| 06/13/2001 | EP1105051A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 06/13/2001 | EP0814778B1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 06/13/2001 | EP0805858B1 Inhibition of neovascularization using vegf-specific oligonucleotides |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | EP0789581B1 Method for the prevention and treatment of bovine mastitis |
| 06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
| 06/13/2001 | EP0710103B1 Pharmaceutical compositions for hardly soluble active substances |
| 06/13/2001 | EP0675728B1 Products and methods for improving keratinocyte adhesion to the dermis |
| 06/13/2001 | EP0656010B1 Use of peptides causing a immune response for the preparation of medicaments to induce the suppression of the immune reaction. |
| 06/13/2001 | EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/13/2001 | DE19959934A1 New heparin-binding proteins from glial cells, useful for treating injuries to the central nervous system, induce regeneration of synaptic connections |
| 06/13/2001 | DE19957689A1 Proteaseresistenter Tumorsuppressor p14(ARF) Protease-resistant tumor suppressor p14 (ARF) |
| 06/13/2001 | DE19957388A1 Chondroinduktive und implantierbare Substrate zur Knorpelheilung und -protektion Chondroinductive and implantable substrates for cartilage healing and -protektion |
| 06/13/2001 | CN1299417A Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299407A Vascular endothelial growth factor 2 |
| 06/13/2001 | CN1299370A Protein purification by ion exchange chromatography |
| 06/13/2001 | CN1299369A Plasminogen-related gene B polypeptides |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299285A Recombinant human interferon beta-1A (IFN-beta-1A) formulation |
| 06/13/2001 | CN1299275A Drugs for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 06/13/2001 | CN1299273A Sticking plaster for controlled release of natural interferon |
| 06/13/2001 | CN1299257A Use of corneal hardening agent in enzyme orthokeratology |
| 06/13/2001 | CN1298945A Human ribonuclease PH and its coding sequence |
| 06/13/2001 | CN1298944A Protein tyrosine kinase 50 and polynucleotide for coding said polypeptide |
| 06/13/2001 | CN1298883A Preparing process and application of recombined human interleukin-11 |
| 06/13/2001 | CN1066964C Microcapsules, method of making same and their use |
| 06/13/2001 | CN1066962C Teeth nuring agent |
| 06/13/2001 | CN1066961C Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin |
| 06/13/2001 | CN1066960C Carious-tooth resistant composition and its prepn. method |
| 06/12/2001 | US6245969 A polypeptide for producing genetically engineered plants having a phenotype of increased crop yield, enhanced disease resistance and longer-lived vegetative growth phase |
| 06/12/2001 | US6245904 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 06/12/2001 | US6245900 Polypeptide wherein at least one of the amino, carboxyl, mercapto or guanidino groups in a polypeptide molecule having human granulocyte colony stimulating factor activity is chemically modified by a maleic acid styrene polymer |
| 06/12/2001 | US6245899 Composition for detection of cell density signal molecule |
| 06/12/2001 | US6245898 Antibodies that inhibit tumor metastasis; diagnosis and therapy of metastic cancers |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245895 Antigen/antibody specificity exchanger |
| 06/12/2001 | US6245893 Receptor that binds anti-convulsant compounds |
| 06/12/2001 | US6245889 BMP-4 products |
| 06/12/2001 | US6245888 Proteins involved in the regulation of cell—cell adhesion and uses thereof |
| 06/12/2001 | US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245883 An isolated lectin derived peptide; therapy, antiinflammatory agent, suppressing cell adhesion, antimetastasis agents |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245787 Composition containing amlodipine or a pharmaceutically acceptable salt thereof, and an ACE inhibitor |
| 06/12/2001 | US6245764 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245752 Antigenic carbohydrate determinant; anticarcinogenic agents |
| 06/12/2001 | US6245751 Administering peptide fragment as protease inhibitor; alzheimer*s disease treatment |
| 06/12/2001 | US6245749 Nucleosides with anti-hepatitis B virus activity |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245746 Administering amide microbiocide antibiotic |
| 06/12/2001 | US6245744 Antilipemic agents |
| 06/12/2001 | US6245743 Inhibitors of factor Xa |
| 06/12/2001 | US6245742 Antitumor, anticarcinogenic and antimetastasis agents; viricides, psoriasis, antiinflammatory agents, antiallergens, psoriasis |
| 06/12/2001 | US6245741 Protein Z-dependent protease inhibitor |
| 06/12/2001 | US6245740 Polyol:oil suspensions for the sustained release of proteins |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease |
| 06/12/2001 | US6245735 Conjugate of antibiotic and polypeptide of cystic fibrosis transmembrane conductance regulator or lipopolysaccharide binding fragment |
| 06/12/2001 | US6245734 Activate apoptosis on human pancreatic adenocarcinoma cells |
| 06/12/2001 | US6245565 Recombinase Mediated DNA modifications |
| 06/12/2001 | US6245563 Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245560 Vector with multiple target response elements affecting gene expression |
| 06/12/2001 | US6245550 Nucleotide sequence from gene homologous to erythropoetin and growth hormone; diagnosis; therapy of blood disorders, developmental/growth defects, and obesity; anti-inflammatory, antidiabetic, anticarcinogenic agents |
| 06/12/2001 | US6245548 In the absence of additional coagulation factors; functions to prevent further bleeding, styptic agent; simple, efficient non-enzymatic production method |